Low
₹
High
₹
| Previous Close | |
|---|---|
| Day's Range | N/A - N/A |
| Open | |
| 52 Week Range | N/A - N/A |
| Volume |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Cipla Ltd. | 1337.00 | |
Healthcare |
| State Bank Of India | 957.00 | |
Bank |
| Titan Company Ltd. | 4299.00 | |
Diamond & Jewellery |
| HDFC Bank Ltd. | 692.10 | |
Bank |
| Kotak Mahindra Bank Ltd. | 430.10 | |
Bank |
| Grasim Industries Ltd. | 2898.00 | |
Diversified |
| Reliance Industries Ltd. | 1190.00 | |
Crude Oil |
| Pidilite Industries Ltd. | 1514.00 | |
Chemicals |
| Shree Cement Ltd. | 22760.00 | |
Construction Materials |
| Tata Power Company Ltd. | 346.00 | |
Power |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 22600.0 | 26373.20 | 22179.90 |
| Nifty IT | 31995.5 | 40301.40 | 25699.10 |
| Nifty Next 50 | 65828.6 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 8248.05 | 10443.40 | 7839.85 |
| Nifty Bank | 54287.35 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 55800.65 | 64450.90 | 52032.85 |
| Nifty 500 | 21427.6 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 16066.4 | 18500.95 | 14804.55 |
| Nifty 100 | 23465.05 | 26975.15 | 22720.45 |
| Nifty FMCG | 42680.7 | 57445.20 | 42146.10 |
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that an inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen Pharmaceuticals Inc. (InvaGen) (wholly owned subsidiary of the Company) located in Hauppauge, Long Island, New York, USA from 19th October, 2026 to 22nd October 2026 (ET). The Inspection was a routine current Good Manufacturing Practices (cGMP) Inspection. The inspection concluded with zero Form 483 observations.
The above information is a part of company’s filings submitted to BSE.
In continuation to earlier intimation dated October 19, 2026 pursuant to the provisions of Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, wherein the Company had provided a preintimation regarding its schedule of analyst(s)/institutional investor(s) meet to be held on October 23, 2026, ICICI Lombard General Insurance Company has informed that due to unavoidable circumstances, referred meeting stands cancelled.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of index is ₹ as of .
The total volume of index is as of .
The percentage change in value of index is % as of .
The absolute increase in index value since the previous trading day is ₹ as of .
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.